bpc-157 for fibromyalgia Rapid Release BPC DELAYED - 250MCG |
Description
The end customer received the product more than 14 days ago
(August 2008)
The compound has not progressed through a drug-approval pathway in any major jurisdiction
Naltrexone, approved in 1984, introduced a non-opioid antagonist that blocked the effects of opioids but required full detoxification before initiation, limiting its early use
